Researchers are using artificial intelligence to reduce the dose of a contrast agent that may be left behind in the body after MRI exams, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA). Gadolinium is a heavy metal used in contrast material that enhances images on MRI. Recent studies have found that trace amounts of the metal remain in the…
Contrast enhanced ultrasound (CEUS) has proved in trials to be more accurate than computed tomography and MRI and can help eliminate the need for unnecessary biopsies and surgery. Led by Dr Richard Barr, Professor of Radiology at Northeast Ohio Medical University, the team has been using CEUS since 1999 and, for the specific study, focused on 721 patients referred for contrast-enhanced ultrasound…
Gadolinium-containing/gadolinium-based contrast agents (GCCAs/GBCAs) and their usage was a major topic at ECR 2018. Fuelled by the current debate a number of presentations focused on possible impact, risks and necessities. Some were highly specific, others took a broader view. The only consensus, however, seems to be the need for more research and the focus on safety. Three ECR speakers, Joseph…
The European Medicines Agency (EMA) decided to suspend authorisation for certain linear gadolinium agents. The review by the Committee for Medicinal Products for Human Use (CHMP) states: “There is currently no evidence that gadolinium deposition in the brain has caused any harm to patients; however EMA has recommended restrictions and suspensions for some intravenous linear agents in order to…
Radiologists must ensure precise scientific data and radiology-based evidence are used to regulate the use of Gadolinium Containing Contrast Agents (GCCAs), a Spanish leading radiologist explained in closed-door leadership meeting earlier this year in Barcelona.
NIH-supported researchers at Massachusetts General Hospital (MGH) are studying an alternative to the contrast agents currently used for magnetic resonance imaging. In a recent study, they showed that the experimental alternative, a manganese-based compound, performs as well as approved contrast agents. Their study appeared online in Radiology. Magnetic resonance (MR) images are taken so that a…
In April 2016 CEUS received the USA’s FDA approval. This year‘s RSNA Samsung Symposium ‘Contrast-Enhanced Ultrasound (CEUS): Innovations and a Problem-Solving Tool in Clinical Practice’ provided an opportunity to take stock. For European Hospital, Professor André Clevert, Director of the Interdisciplinary Centre for Ultrasound at University Hospital Munich, Germany, describes the current…
Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to the results of a study presented by Mayo Clinic researchers at the 2017 San Antonio Breast Cancer Symposium. “Our study aimed to compare contrast-enhanced mammography with breast MRI in evaluating residual breast cancer in…
The ability to demonstrate blood perfusion as well as organ function using contrast agentenhanced ultrasound is quickly finding innovative uses in clinical practice. Contrast-enhanced ultrasound (CEUS) has advanced rapidly since its first introduction. Today it is widely used as a primary imaging technique for a number of indications and pathologies. At a symposium organised by Bracco Imaging…
A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing types.
Scientists from the German Cancer Research Center (DKFZ), in collaboration with colleagues from Heidelberg University Hospital, have been able to visualize brain cancer using a novel MRI method. They use a simple sugar solution instead of conventional contrast agents, which can have side effects in the body.
NEW: Evolution 3.0 EPIQ ultrasound upgrade offers high-res PureWave crystal transducer technology, shear wave elastography, contrast enhanced ultrasound, and image fusion. Could you ask for more?
Contrast enhanced ultrasound is part of clinical routine and makes a substantial contribution towards increasing the significance of tissue and organ diagnosis with ultrasound for difficult cases.
Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, today announced the approval of the use of MultiHance® (gadobenate dimeglumine) in Magnetic Resonance Imaging (MRI) of the whole body in adults and paediatric patients (> 2 years). The approval was obtained through a Mutual Recognition Procedure, with the Medicines and Healthcare products Regulatory Agency…
SIGNA Pioneer, a new 3.0 T Magnetic Resonance Imaging (MRI) system, embodies the exploration and expansion of modern medical imaging and blazes a trail to the future of MRI. Dr. Ahlers, general manager of radiomed, shares his experience with SIGNA Pioneer recently installed at radiomed practice in Wiesbaden, Germany – one of the first installations worldwide.
The prostate remains the only organ where random biopsies are performed to find cancer, notes Jean-Michel Correas MD PhD, from the Necker University Hospital in Paris. If we proposed this approach to a woman to search for breast cancer, it would be outrageous, he said.
Paediatric imaging is a subspecialty that uses a diverse range of imaging systems, from classical X-ray to ultrasound, CT and MR.
Using an iodinated contrast agent, I-View software on the Hologic tomosynthesis system enables the user to image the functional 2-D contrast uptake and the morphological mammography images in rapid sequence and combine these three image sets into a single co-registered study.
For medical ultrasound it’s quick, easy and portable – and so popular with Professor Christoph Dietrich, chief of Medical Department 2 at Caritas Hospital, Bad Mergentheim, one of the first physicians worldwide to test the M9 in clinical routine. ‘The compact Mindray colour Doppler system is about the same size as a notebook computer. The imaging suite comes to the patient,’ the…
Once considered an add-on examination, CEUS expands diagnostic capabilities and is leading to new insights. Where contrast enhanced ultrasound (CEUS) is restricted to radiologists, or performed only by trained technicians, its utilisation has stabilised, taking its place among more established imaging modalities. Report: John Brosky
In the USA, some patients have bled to death while in the CT scanner because this type of examination takes too long for blunt abdominal trauma diagnosis. Report: Chrissanthi Nikolakudi
Ultrasound Contrast Agent SonoVue usable in case of recent acute coronary syndrome or clinically unstable ischaemic cardiac disease.
Bracco Imaging, a global leading company in diagnostic imaging announced the launch of MultiHance (active ingredient: adobenate dimeglumine) in Russia.
Mammography scans with lower dose and higher contrast – that’s the declared goal of Dr Nik Hauser, Medical Director of the Women‘s Clinic and Director of the Interdisciplinary Breast Centre at Kantonsspital Baden, Switzerland, and Professor Marco Stampanoni of Paul Scherrer Institute in Villigen, Switzerland.
However, investments in equipment and advanced training are attracting medical students, John Brosky reports